glp 1 agonisten GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Impact of GLP- 1 Receptor
Description
Not vague advice
Trends Pharmacol Sci 2018;39:36786.PubMed 45
Nat Commun (2022) 13:1057
Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, et al
At the moment, some medications can collaborate in the treatment of MASLD, some of them approved for the treatment of comorbidities such as GLP-1 agonists indicated for the treatment of T2DM or obesity, but also with benefit in the MASH treatment (9, 10)
For pharmacies, these differences translate into distinct dispensing patterns
